{"id":39654,"date":"2026-01-28T22:33:19","date_gmt":"2026-01-28T21:33:19","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&#038;p=39654"},"modified":"2026-05-21T22:51:06","modified_gmt":"2026-05-21T20:51:06","slug":"pe-22-28-10mg","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/de\/shop\/pe-22-28-10mg\/","title":{"rendered":"PE 22-28 10mg"},"content":{"rendered":"<p data-start=\"142\" data-end=\"209\"><strong data-start=\"142\" data-end=\"209\">PE-22-28 - Proenkephalin-abgeleitetes Neuropeptid-Forschungspr\u00e4parat<\/strong><\/p>\n<p data-start=\"211\" data-end=\"496\"><strong data-start=\"211\" data-end=\"227\">Zusammensetzung:<\/strong> PE-22-28 (10 mg lyophilisiertes Peptidpulver)<br data-start=\"271\" data-end=\"274\" \/><strong data-start=\"274\" data-end=\"287\">Kategorie:<\/strong> Peptid<br data-start=\"295\" data-end=\"298\" \/><strong data-start=\"298\" data-end=\"307\">Form:<\/strong> 10 mg Fl\u00e4schchen mit gefriergetrocknetem Pulver<br data-start=\"343\" data-end=\"346\" \/><strong data-start=\"346\" data-end=\"365\">Verwaltung:<\/strong> Subkutane oder zentrale Forschungsanwendung nach Rekonstitution mit sterilem oder bakteriostatischem Wasser (je nach Studiendesign)<\/p>\n<hr data-start=\"498\" data-end=\"501\" \/>\n<h3 data-start=\"503\" data-end=\"524\">Was ist PE-22-28?<\/h3>\n<p data-start=\"526\" data-end=\"700\">PE-22-28 ist ein <strong data-start=\"540\" data-end=\"575\">synthetisches Neuropeptid-Fragment<\/strong> abgeleitet von <strong data-start=\"589\" data-end=\"608\">Proenkephalin A<\/strong>, ein endogenes Vorl\u00e4uferprotein, das an Opioid- und neuroregulatorischen Signalwegen beteiligt ist.<\/p>\n<p data-start=\"702\" data-end=\"1050\">Dieses Peptid wurde auf seine Rolle bei der <strong data-start=\"748\" data-end=\"785\">Modulation des zentralen Nervensystems<\/strong>, insbesondere in Bezug auf <strong data-start=\"815\" data-end=\"891\">dopaminerges Gleichgewicht, Prolaktinregulierung und neuroendokrine Signal\u00fcbertragung<\/strong>.<br data-start=\"892\" data-end=\"895\" \/>Anders als klassische Opioidpeptide zeigt PE-22-28 <strong data-start=\"951\" data-end=\"989\">nicht-analgetische, regulierende Wirkung<\/strong>, Das macht es zu einer besonderen Verbindung in der Neuropeptidforschung.<\/p>\n<p data-start=\"1052\" data-end=\"1225\">In der Forschung wird PE-22-28 (10 mg) auf seinen Einfluss auf <strong data-start=\"1128\" data-end=\"1224\">Regulierung von Neurotransmittern, Motivationssignalen und Interaktionen zwischen Hypothalamus und Hypophyse<\/strong>.<\/p>\n<p data-start=\"1227\" data-end=\"1328\">\u27a1\ufe0f Ideal f\u00fcr die Neuropeptidforschung, ZNS-Signalstudien und die Untersuchung neuroendokriner Signalwege.<\/p>\n<hr data-start=\"1330\" data-end=\"1333\" \/>\n<h3 data-start=\"1335\" data-end=\"1360\">Wichtige Forschungsergebnisse<\/h3>\n<p data-start=\"1362\" data-end=\"1460\">Neuroregulierende Aktivit\u00e4t: Untersucht auf seine modulierende Rolle innerhalb der zentralen Neurotransmittersysteme.<\/p>\n<p data-start=\"1462\" data-end=\"1576\">Dopaminerge Interaktion: Assoziiert mit der Regulierung von Dopamin-verkn\u00fcpften Signalwegen in experimentellen Modellen.<\/p>\n<p data-start=\"1578\" data-end=\"1687\">Forschung zur Modulation von Prolaktin: Erforscht wird der Einfluss auf prolaktinbezogene neuroendokrine Mechanismen.<\/p>\n<p data-start=\"1689\" data-end=\"1771\">Nicht-Opioid-Funktionsprofil: Weist keinen klassischen Opioidrezeptor-Agonismus auf.<\/p>\n<p data-start=\"1773\" data-end=\"1865\">ZNS-spezifisches Interesse: In erster Linie relevant f\u00fcr zentrale und nicht f\u00fcr periphere Forschungsmodelle.<\/p>\n<hr data-start=\"1867\" data-end=\"1870\" \/>\n<h3 data-start=\"1872\" data-end=\"1895\">Mechanismus der Wirkung<\/h3>\n<p data-start=\"1897\" data-end=\"1993\">Es wird vermutet, dass PE-22-28 seine Wirkung \u00fcber zentrale neuroregulatorische Mechanismen entfaltet, darunter:<\/p>\n<p data-start=\"1995\" data-end=\"2092\">Modulation von Neurotransmittern \u2192 Interaktion mit dopaminergen und neuroendokrinen Signalkreisl\u00e4ufen<\/p>\n<p data-start=\"2094\" data-end=\"2177\">Einfluss des hypothalamischen Weges \u2192 Modulation hypophysenbezogener Signalkaskaden<\/p>\n<p data-start=\"2179\" data-end=\"2256\">Rezeptor-vermittelte Regulierung \u2192 Indirekte Interaktion mit ZNS-Rezeptorsystemen<\/p>\n<p data-start=\"2258\" data-end=\"2334\">Zentrales Aktivit\u00e4tsprofil \u2192 Fokussierte Wirkungen im zentralen Nervensystem<\/p>\n<hr data-start=\"2336\" data-end=\"2339\" \/>\n<h3 data-start=\"2341\" data-end=\"2365\">Dosierung und Anwendung<\/h3>\n<p data-start=\"2367\" data-end=\"2428\">Vor Gebrauch mit sterilem oder bakteriostatischem Wasser rekonstituieren.<\/p>\n<p data-start=\"2430\" data-end=\"2639\">Die Forschungsschwerpunkte variieren je nach Versuchsaufbau und Protokollanforderungen.<br data-start=\"2518\" data-end=\"2521\" \/>Ein 10-mg-Fl\u00e4schchen eignet sich f\u00fcr Studien mit mehreren Neuropeptiden, Dosis-Wirkungs-Experimente oder l\u00e4ngere Forschungsprotokolle.<\/p>\n<p data-start=\"2641\" data-end=\"2712\">Die rekonstituierte L\u00f6sung k\u00fchl lagern und innerhalb von 2-3 Wochen aufbrauchen.<\/p>\n<hr data-start=\"2714\" data-end=\"2717\" \/>\n<h3 data-start=\"2719\" data-end=\"2743\">Anweisungen zur Lagerung<\/h3>\n<p data-start=\"2745\" data-end=\"2867\">Lagerung bei 2-8 \u00b0C (36-46 \u00b0F)<br data-start=\"2771\" data-end=\"2774\" \/>Vor Licht und Feuchtigkeit sch\u00fctzen<br data-start=\"2805\" data-end=\"2808\" \/>Nicht einfrieren<br data-start=\"2821\" data-end=\"2824\" \/>Rekonstituierte L\u00f6sung innerhalb von 2-3 Wochen verwenden<\/p>\n<hr data-start=\"2869\" data-end=\"2872\" \/>\n<h3 data-start=\"2874\" data-end=\"2906\">Warum PE-22-28 (10 mg) w\u00e4hlen?<\/h3>\n<p data-start=\"2908\" data-end=\"3148\">PE-22-28 wird in Forschungsumgebungen wegen seiner <strong data-start=\"2960\" data-end=\"3022\">einzigartige Position innerhalb der Proenkephalin-abgeleiteten Neuropeptide<\/strong>, und bietet einen Einblick in <strong data-start=\"3046\" data-end=\"3117\">Dopamin-regulierte und Prolaktin-assoziierte neuroendokrine Signalwege<\/strong> ohne direkte opioide Wirkungen.<\/p>\n<p data-start=\"3150\" data-end=\"3335\">Aufgrund seiner Spezifit\u00e4t und seines zentralen Aktivit\u00e4tsprofils ist es besonders geeignet f\u00fcr <strong data-start=\"3229\" data-end=\"3334\">fortgeschrittene ZNS-Forschung, Studien zur Neuropeptid-Signal\u00fcbertragung und zur Hypothalamus-Hypophysen-Achse<\/strong>.<\/p>\n<p data-start=\"3337\" data-end=\"3483\"><strong data-start=\"3337\" data-end=\"3363\">PE-22-28 (10 mg) bestellen<\/strong> und sein Potenzial f\u00fcr die fortgeschrittene Neuropeptidforschung, die Analyse von ZNS-Signalen und neuroendokrine Untersuchungen erkunden.<\/p>","protected":false},"excerpt":{"rendered":"<p>PE-22-28 \u2013 Proenkephalin-Derived Neuropeptide Research Compound Composition: PE-22-28 (10 mg lyophilized peptide powder)Category: PeptideForm: 10 mg vial with freeze-dried powderAdministration: Subcutaneous or central research application after reconstitution with sterile or bacteriostatic water (depending on study design) What is PE-22-28? PE-22-28 is a synthetic neuropeptide fragment derived from Proenkephalin A, an endogenous precursor protein involved in opioid and neuroregulatory signaling pathways. This peptide has been studied for its role in central nervous system modulation, particularly in relation to dopaminergic balance, prolactin regulation, and neuroendocrine signaling.Unlike classical opioid peptides, PE-22-28 demonstrates non-analgesic, regulatory activity, making it a distinct compound within neuropeptide research. In research settings, PE-22-28 (10 mg) is investigated for its influence on neurotransmitter regulation, motivational signaling, and hypothalamic-pituitary interactions. \u27a1\ufe0f Ideal for neuropeptide research, CNS signaling studies, and neuroendocrine pathway investigations. Key Research Findings Neuroregulatory Activity: Studied for its modulatory role within central neurotransmitter systems. Dopaminergic Interaction: Associated with regulation of dopamine-linked signaling pathways in experimental models. Prolactin Modulation Research: Investigated for its influence on prolactin-related neuroendocrine mechanisms. Non-Opioid Functional Profile: Does not exhibit classical opioid receptor agonism. CNS-Specific Interest: Primarily relevant to central rather than peripheral research models. Mechanism of Action PE-22-28 is believed to exert its effects through central neuroregulatory mechanisms, including: Neurotransmitter Modulation \u2192 Interaction with dopaminergic and neuroendocrine signaling circuits Hypothalamic Pathway Influence \u2192 Modulation of pituitary-related signaling cascades Receptor-Mediated Regulation \u2192 Indirect interaction with CNS receptor systems Central Activity Profile \u2192 Focused effects within the central nervous system Dosage &amp; Application Reconstitute with sterile or bacteriostatic water before use. Research concentrations vary depending on experimental design and protocol requirements.A 10 mg vial is suitable for multiple neuropeptide studies, dose-response experiments, or extended research protocols. Store the reconstituted solution refrigerated and use within 2\u20133 weeks. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F)Protect from light and moistureDo not freezeUse reconstituted solution within 2\u20133 weeks Why Choose PE-22-28 (10 mg)? PE-22-28 is valued in research environments for its unique position within proenkephalin-derived neuropeptides, offering insight into dopamine-regulated and prolactin-associated neuroendocrine pathways without direct opioid effects. Its specificity and central activity profile make it particularly relevant for advanced CNS research, neuropeptide signaling studies, and hypothalamic-pituitary axis investigations. Order PE-22-28 (10 mg) and explore its potential in advanced neuropeptide research, CNS signaling analysis, and neuroendocrine investigations.<\/p>","protected":false},"featured_media":39640,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,26,27],"product_tag":[],"class_list":["post-39654","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-neuroandvascularprotection","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product\/39654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/comments?post=39654"}],"version-history":[{"count":1,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product\/39654\/revisions"}],"predecessor-version":[{"id":39655,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product\/39654\/revisions\/39655"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/media\/39640"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/media?parent=39654"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product_brand?post=39654"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product_cat?post=39654"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/de\/wp-json\/wp\/v2\/product_tag?post=39654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}